{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:17:26Z","timestamp":1783441046800,"version":"3.54.6"},"reference-count":56,"publisher":"Bioscientifica","issue":"5","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":308,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>There is no consensus regarding methods to estimate kidney function in hyperthyroidism. The aim was therefore to assess changes in filtration markers in patients with Graves\u2019 disease undergoing treatment with antithyroid drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty patients with de novo Graves\u2019 disease were included. Blood sampling, including thyroid-stimulating hormone, fT3, fT4 and creatinine, was performed at baseline, 6 weeks, 3, 6, 12 and 24 months. Cystatin C was measured from frozen samples. To calculate creatinine- and cystatin C-based eGFR, the Lund\u2013Malm\u00f6 equation (LMR) and the CAPA formula were used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>fT3 and fT4 normalized during treatment. Creatinine increased initially but stabilized after 6 months. eGFRLMR decreased until 12 months. Cystatin C decreased, while eGFRCAPA and eGFRCAPA\/eGFRLMR increased until 6 months. The mean of eGFRLMR and eGFRCAPA remained stable. The % changes in creatinine and cystatin C were associated with % changes in fT3 and fT4. In regression models including fT3 or fT4 with body weight (all % change), fT3 and fT4 were the strongest predictors of percentual changes in both creatinine and cystatin C.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The increase in creatinine and decrease in cystatin C during the treatment of Graves\u2019 disease was significantly associated with changes in thyroid hormones, and for creatinine, also body weight. The mean of eGFRLMR and eGFRCAPA remained stable, suggesting that creatinine and cystatin C were affected by different non-GFR-related factors. The potential use of eGFRLMR and eGFRCAPA to assess kidney function in patients with thyroid disorders should be further evaluated in studies measuring kidney function with state-of-the-art methods.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/ec-24-0698","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T07:35:46Z","timestamp":1744097746000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":2,"title":["Estimation of kidney function in Graves\u2019 disease using creatinine and cystatin C"],"prefix":"10.1530","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3367-4902","authenticated-orcid":true,"given":"Sorena","family":"Abbaszadeh","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, Endocrinology and Mineral Metabolism, Uppsala University 1 , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9348-4603","authenticated-orcid":true,"given":"Martin H","family":"Lundqvist","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Clinical Diabetology and Metabolism, Uppsala University 2 , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3150-6122","authenticated-orcid":true,"given":"\u00d6sten","family":"Ljunggren","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Endocrinology and Mineral Metabolism, Uppsala University 1 , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3161-0402","authenticated-orcid":true,"given":"Anders Olof","family":"Larsson","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Clinical Chemistry, Uppsala University 3 , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7545-5585","authenticated-orcid":true,"given":"Maria K","family":"Svensson","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Renal Medicine, Uppsala University 4 , ,","place":["Uppsala, Sweden"]},{"name":"Uppsala Clinical Research Center, Uppsala University 5 , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9176-8095","authenticated-orcid":true,"given":"Selwan","family":"Khamisi","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Endocrinology and Mineral Metabolism, Uppsala University 1 , ,","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"2026070710575310400_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/eje.1.02093","article-title":"Vascular and renal function in experimental thyroid disorders","volume":"154","author":"Vargas","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2026070710575310400_bib2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/EJE-11-0548","article-title":"Incidence of hyperthyroidism in Sweden","volume":"165","author":"Abraham-Nordling","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2026070710575310400_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101387","article-title":"Graves\u2019 disease: epidemiology, genetic and environmental risk factors and viruses","volume":"34","author":"Antonelli","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"2026070710575310400_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40618-014-0214-2","article-title":"Role of genetic and non-genetic factors in the etiology of Graves\u2019 disease","volume":"38","author":"Marin\u00f2","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"2026070710575310400_bib5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4103\/2230-8210.93737","article-title":"Interactions between thyroid disorders and kidney disease","volume":"16","author":"Basu","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"2026070710575310400_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1681\/ASN.2010070766","article-title":"The renal manifestations of thyroid disease","volume":"23","author":"Mariani","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2026070710575310400_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.769335","article-title":"The glomerular filtration rate: from the diagnosis of kidney function to a public health tool","volume":"8","author":"Cusumano","year":"2021","journal-title":"Front Med"},{"key":"2026070710575310400_bib8","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/ckj\/sfab042","article-title":"Assessment of kidney function: clinical indications for measured GFR","volume":"14","author":"Ebert","year":"2021","journal-title":"Clin Kidney J"},{"key":"2026070710575310400_bib9","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1046\/j.1523-1755.2003.00925.x","article-title":"Impact of thyroid dysfunction on serum cystatin C","volume":"63","author":"Fricker","year":"2003","journal-title":"Kidney Int"},{"key":"2026070710575310400_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100710","article-title":"Discordance between creatinine-based and cystatin C-based estimated GFR: interpretation according to performance compared to measured GFR","volume":"5","author":"Wang","year":"2023","journal-title":"Kidney Med"},{"key":"2026070710575310400_bib11","first-page":"21","article-title":"Human cysteine proteinase inhibitors. Isolation, physiological importance, inhibitory mechanism, gene structure and relation to hereditary cerebral hemorrhage","volume":"191","author":"Abrahamson","year":"1988","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"2026070710575310400_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/bj2680287","article-title":"Structure and expression of the human cystatin C gene","volume":"268","author":"Abrahamson","year":"1990","journal-title":"Biochem J"},{"key":"2026070710575310400_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1590\/2175-8239-jbn-2019-0240","article-title":"Cystatin C: not just a marker of kidney function","volume":"42","author":"Fernando","year":"2020","journal-title":"J Bras Nefrol"},{"key":"2026070710575310400_bib14","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.2215\/CJN.00800208","article-title":"Prevalence of subclinical hypothyroidism in patients with chronic kidney disease","volume":"3","author":"Chonchol","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026070710575310400_bib15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10157-012-0727-y","article-title":"Thyroid hormone replacement therapy for primary hypothyroidism leads to significant improvement of renal function in chronic kidney disease patients","volume":"17","author":"Hataya","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"2026070710575310400_bib16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MED.0000000000000275","article-title":"The interaction between thyroid and kidney disease: an overview of the evidence","volume":"23","author":"Rhee","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2026070710575310400_bib17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12882-023-03111-7","article-title":"Subclinical thyroid dysfunction and chronic kidney disease: a nationwide population-based study","volume":"24","author":"Kim","year":"2023","journal-title":"BMC Nephrol"},{"key":"2026070710575310400_bib18","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1210\/jc.2012-1663","article-title":"Preservation of renal function by thyroid hormone replacement therapy in chronic kidney disease patients with subclinical hypothyroidism","volume":"97","author":"Shin","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710575310400_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3803\/EnM.2021.1333","article-title":"Graves\u2019 disease and the risk of end-stage renal disease: a Korean population-based study","volume":"37","author":"Cho","year":"2022","journal-title":"Endocrinol Metab"},{"key":"2026070710575310400_bib20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0026-0495(92)90075-L","article-title":"Alteration of renal function in hyperthyroidism: increased tubular secretion of creatinine and decreased distal tubule delivery of chloride","volume":"41","author":"Shirota","year":"1992","journal-title":"Metab Clin Exp"},{"key":"2026070710575310400_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12020-019-01903-2","article-title":"Hyperthyroidism influences renal function","volume":"65","author":"S\u00f6nmez","year":"2019","journal-title":"Endocrine"},{"key":"2026070710575310400_bib22","article-title":"Thyroid dysfunction and renal function: a crucial relationship to recognize","volume":"15","author":"Naguib","year":"2023","journal-title":"Cureus"},{"key":"2026070710575310400_bib23","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1210\/jc.2013-2312","article-title":"Hyperthyroidism increases brown fat metabolism in humans","volume":"99","author":"Lahesmaa","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710575310400_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9863050","article-title":"Changes in body compositions and basal metabolic rates during treatment of Graves\u2019 disease","volume":"2018","author":"Kim","year":"2018","journal-title":"Int J Endocrinol"},{"key":"2026070710575310400_bib25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000512078","article-title":"Body weight changes in hyperthyroidism: timing and possible explanations during a one year repeated measurement study","volume":"10","author":"Karmisholt","year":"2021","journal-title":"Eur Thyroid J"},{"key":"2026070710575310400_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12902-022-00981-0","article-title":"Obesity is associated with subclinical hypothyroidism in the presence of thyroid autoantibodies: a cross-sectional study","volume":"22","author":"Yan","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"2026070710575310400_bib27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2215\/CJN.02870707","article-title":"Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C","volume":"3","author":"Baxmann","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026070710575310400_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000329354","article-title":"Influence of thyroid function on different kidney function tests","volume":"35","author":"Kimmel","year":"2012","journal-title":"Kidney Blood Press Res"},{"key":"2026070710575310400_bib29","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cca.2015.10.018","article-title":"Paradoxical effects of thyroid function on glomerular filtration rate estimated from serum creatinine or standardized cystatin C in patients with Japanese Graves\u2019 disease","volume":"451","author":"Suzuki","year":"2015","journal-title":"Clin Chim Acta"},{"key":"2026070710575310400_bib30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3341\/kjo.2020.0006","article-title":"Serum cystatin C concentrations in patients with Graves\u2019 ophthalmopathy","volume":"34","author":"Can","year":"2020","journal-title":"Korean J Ophthalmol"},{"key":"2026070710575310400_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4158\/EP12282.OR","article-title":"Impact of thyroid function on serum cystatin C and estimated glomerular filtration rate: a cross-sectional study","volume":"19","author":"Ye","year":"2013","journal-title":"Endocr Pract"},{"key":"2026070710575310400_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.766516","article-title":"Association between serum cystatin C and thyroid diseases: a systematic review and meta-analysis","volume":"12","author":"Xin","year":"2021","journal-title":"Front Endocrinol"},{"key":"2026070710575310400_bib33","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s40618-021-01505-8","article-title":"Serum thyroglobulin is associated with orbitopathy in Graves\u2019 disease","volume":"44","author":"Khamisi","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"2026070710575310400_bib34","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/thy.2023.0162","article-title":"Fracture incidence in Graves\u2019 disease: a population-based study","volume":"33","author":"Khamisi","year":"2023","journal-title":"Thyroid"},{"key":"2026070710575310400_bib35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40618-022-01927-y","article-title":"Vitamin D and bone metabolism in Graves\u2019 disease: a prospective study","volume":"46","author":"Khamisi","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"2026070710575310400_bib36","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3109\/00365513.2011.557086","article-title":"Revised equations for estimating glomerular filtration rate based on the Lund\u2013Malm\u00f6 Study cohort","volume":"71","author":"Bj\u00f6rk","year":"2011","journal-title":"Scand J Clin Lab Invest"},{"key":"2026070710575310400_bib37","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1373\/clinchem.2013.220707","article-title":"Generation of a new cystatin C-based estimating equation for glomerular filtration rate by use of 7 assays standardized to the international calibrator","volume":"60","author":"Grubb","year":"2014","journal-title":"Clin Chem"},{"key":"2026070710575310400_bib38","doi-asserted-by":"crossref","first-page":"R139","DOI":"10.1186\/cc3044","article-title":"Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients","volume":"9","author":"Villa","year":"2005","journal-title":"Crit Care"},{"key":"2026070710575310400_bib39","doi-asserted-by":"crossref","first-page":"e932","DOI":"10.1097\/CCM.0000000000002537","article-title":"Superiority of serum cystatin C over creatinine in prediction of long-term prognosis at discharge from ICU","volume":"45","author":"Ravn","year":"2017","journal-title":"Crit Care Med"},{"key":"2026070710575310400_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12882-019-1201-9","article-title":"Impact of thyroid function on cystatin C in detecting acute kidney injury: a prospective, observational study","volume":"20","author":"Zhang","year":"2019","journal-title":"BMC Nephrol"},{"key":"2026070710575310400_bib41","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2215\/CJN.0000000000000203","article-title":"Comparison of cystatin C and creatinine in the assessment of measured kidney function during critical illness","volume":"18","author":"Haines","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026070710575310400_bib42","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF03347201","article-title":"Thyroid function differently affects serum cystatin Cand creatinine concentrations","volume":"28","author":"Manetti","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"2026070710575310400_bib43","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"key":"2026070710575310400_bib44","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.jacc.2018.02.045","article-title":"Thyroid hormones and cardiovascular function and diseases","volume":"71","author":"Razvi","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026070710575310400_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12020-023-03361-3","article-title":"Renal function changes in patients with subclinical hyperthyroidism: a novel postulated mechanism","volume":"82","author":"Allam","year":"2023","journal-title":"Endocrine"},{"key":"2026070710575310400_bib46","first-page":"149","article-title":"Effects of hyper- and hypothyroidism on the basal levels of angiotensin I and kinetic parameters of renin-angiotensin system in male rats","volume":"38","author":"Jim\u00e9nez","year":"1982","journal-title":"Rev Esp Fisiol"},{"key":"2026070710575310400_bib47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00005344-199309000-00016","article-title":"Renin-angiotensin system in thyroid dysfunction in rats","volume":"22","author":"Marchant","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026070710575310400_bib48","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bbrc.2012.02.040","article-title":"Triiodothyronine stimulates cystatin C production in bone cells","volume":"419","author":"Schmid","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"2026070710575310400_bib49","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1177\/147323001003800418","article-title":"Influence of thyroid hormones and transforming growth factor-\u03b21 on cystatin C concentrations","volume":"38","author":"Kotajima","year":"2010","journal-title":"J Int Med Res"},{"key":"2026070710575310400_bib50","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mce.2018.12.004","article-title":"Cystatin C in adipose tissue and stimulation of its production by growth hormone and triiodothyronine in 3T3-L1 cells","volume":"482","author":"Schmid","year":"2019","journal-title":"Mol Cell Endocrinol"},{"key":"2026070710575310400_bib51","article-title":"Cystatin C is glucocorticoid responsive, directs recruitment of Trem2+ macrophages, and predicts failure of cancer immunotherapy","volume":"3","author":"Kleeman","year":"2023","journal-title":"Cell Genom"},{"key":"2026070710575310400_bib52","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/00365510902946992","article-title":"Different equations to combine creatinine and cystatin C to predict GFR. Arithmetic mean of existing equations performs as well as complex combinations","volume":"69","author":"Nyman","year":"2009","journal-title":"Scand J Clin Lab Invest"},{"key":"2026070710575310400_bib53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/00365513.2011.634023","article-title":"Improved estimation of glomerular filtration rate (GFR) by comparison of eGFRcystatin C and eGFRcreatinine","volume":"72","author":"Grubb","year":"2012","journal-title":"Scand J Clin Lab Invest"},{"key":"2026070710575310400_bib54","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12328","article-title":"Weight gain following treatment of hyperthyroidism-A forgotten tale","volume":"9","author":"Kyriacou","year":"2019","journal-title":"Clin Obes"},{"key":"2026070710575310400_bib55","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0022-5347(17)37891-6","article-title":"Iohexol clearance for the determination of glomerular filtration rate in clinical practice: evidence for a new gold standard","volume":"146","author":"Brown","year":"1991","journal-title":"J Urol"},{"key":"2026070710575310400_bib56","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ckj\/sfw070","article-title":"Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1: how to measure glomerular filtration rate with iohexol?","volume":"9","author":"Delanaye","year":"2016","journal-title":"Clin Kidney J"}],"container-title":["Endocrine Connections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/14\/5\/EC-24-0698.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/14\/5\/EC-24-0698.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-24-0698\/9381\/ec-24-0698.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-24-0698\/9381\/ec-24-0698.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:21:51Z","timestamp":1783437711000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article\/14\/5\/e240698\/1373\/Estimation-of-kidney-function-in-Graves-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1530\/ec-24-0698","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"article-number":"e240698"}}